Edoxaban in elderly patient with morbid obesity and atrial fibrillation: the role of plasma levels evaluation for selecting the appropriate dose

  • Vincenzo Russo | v.p.russo@libero.it Cardiology Unit, University of Campania “Luigi Vanvitelli”, Monaldi Hospital, Naples, Italy.
  • Anna Rago Cardiology Unit, University of Campania “Luigi Vanvitelli”, Monaldi Hospital, Naples, Italy.
  • Nunzia Laezza Cardiology Unit, University of Campania “Luigi Vanvitelli”, Monaldi Hospital, Naples, Italy.
  • Pierpaolo Di Micco Division of Internal Medicine, Buonconsiglio Fatebenefratelli Hospital, Naples, Italy.
  • Laura Giannetti Cardiology Unit, University of Campania “Luigi Vanvitelli”, Monaldi Hospital, Naples, Italy.
  • Luigi Atripaldi Chemical Biochemistry Unit, Monaldi Hospital, Naples, Italy.
  • Antonio D'Onofrio Division of Cardiology, Monaldi Hospital, Naples, Italy.
  • Paolo Golino Cardiology Unit, University of Campania “Luigi Vanvitelli”, Monaldi Hospital, Naples, Italy.
  • Gerardo Nigro Cardiology Unit, University of Campania “Luigi Vanvitelli”, Monaldi Hospital, Naples, Italy.

Abstract

We present the case of a 80-year-old man with atrial fibrillation, morbid obesity (weight 123 kg, height 167 cm, BMI 44.1), high clearance of creatinine and pharmacological polytherapy, in which the serial determinations of edoxaban plasma levels help us to choose the appropriate dose.

Downloads

Download data is not yet available.

METRICS

PlumX Metrics provide insights into the ways people interact with individual pieces of research output (articles, conference proceedings, book chapters, and many more) in the online environment. Examples include, when research is mentioned in the news or is tweeted about. Collectively known as PlumX Metrics, these metrics are divided into five categories to help make sense of the huge amounts of data involved and to enable analysis by comparing like with like.

Published
2020-03-20
Info
Issue
Section
Cardiology - Case Reports
Keywords:
atrial fibrillation, obesity, non-vitamin k oral anticoagulant, plasma levels, edoxaban, elderly
Statistics
  • Abstract views: 112

  • PDF: 77
How to Cite
Russo, V., Rago, A., Laezza, N., Di Micco, P., Giannetti, L., Atripaldi, L., D’Onofrio, A., Golino, P., & Nigro, G. (2020). Edoxaban in elderly patient with morbid obesity and atrial fibrillation: the role of plasma levels evaluation for selecting the appropriate dose. Monaldi Archives for Chest Disease, 90(1). https://doi.org/10.4081/monaldi.2020.1224